Highlights
NASDAQ: JNCE       Jounce Therapeutics Inc
Last Price Today's Change   Day's Range   Trading Volume
5.59   +0.66 (13.39%)  5.02 - 5.65  602,300

Overview

 
Avg Volume (4 weeks):199,190
4 Weeks Range:3.22 - 5.65
4 Weeks Price Volatility (%):
97.53%
52 Weeks Range:2.66 - 7.35
52 Weeks Price Volatility (%):
62.47%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Jounce Therapeutics Inc is a clinical stage immunotherapy company. The company is dedicated to transforming the treatment of cancer by developing therapies that enable the immune system to attack tumors and provide long-lasting benefits to patients. The company's strategy is to create immunotherapies targeting a variety of the diverse cellular components of the immune system, as well as non-immune cells resident within the tumor, all of which can vary greatly among tumors within and across indications. This may provide benefit to patients with tumors across the spectrum from highly inflamed, or hot, to poorly inflamed, or cold, and especially those not well served by current therapies. Its lead product candidate, JTX-2011, is a clinical stage monoclonal antibody.

  Be the first to like this.
 


 

4486  3499  717  224 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 CHK 0.702+0.032 
 FCEL 0.81+0.265 
 AMD 37.52+0.81 
 EEM 42.76-0.33 
 ET 11.16-0.50 
 SPY 309.10+0.10 
 GE 11.29-0.13 
 BAC 32.79-0.30 
 DIS 148.72+10.14 
 XLF 29.61-0.19 
Partners & Brokers